NVOX Introduces a New Clinical Network to Streamline ADHD Assessments for Clinicians

NVOX Launches Innovative US Clinical Network for ADHD Assessments

In a groundbreaking move, NVOX has unveiled its new US clinical network, the NVOX Network, focused on streamlining the ADHD assessment process for clinicians. The initiative aims to address significant challenges faced by healthcare professionals in evaluating ADHD, particularly the overwhelming time commitment often required. This new network invites qualified psychologists and psychiatrists to join at no cost, thus enhancing the accessibility and efficiency of ADHD assessments.

For over three and a half years, NVOX worked diligently on developing this comprehensive platform, culminating in more than 1,000 assessments completed during its initial operational phase. The platform was recently presented to clinicians at the American Psychological Association (APA) 2026 conference held in Washington, D.C., where feedback was gathered to refine the rollout further.

A recent study published in the Journal of the American Board of Family Medicine highlighted a troubling trend: less than half of surveyed clinicians are currently offering ADHD assessment services in their practice. This gap is particularly evident among adults, where only 46% reported providing these services, and even lower among children at 42.6%. The study found that time constraints frequently hinder clinician ability to deliver appropriate evaluations, with nearly 40% of clinicians citing lack of time as a significant barrier.

To combat this issue, NVOX’s platform is designed to lighten the clinical workload associated with comprehensive ADHD evaluations. "Effective ADHD assessment goes beyond just identifying symptoms," explained Dr. Johnathan Leemor, NVOX's Chief Science Officer. "It necessitates a thorough developmental history and a clear understanding of the patient's context, information from various sources, and careful interpretation of clinical data. Our platform is structured to facilitate this complexity, allowing clinicians to focus more on understanding the individual rather than being burdened by administrative tasks."

The NVOX Network comprises two primary service options:
1. NVOX Network: This option allows qualified clinicians who either conduct ADHD assessments or wish to incorporate them into their practices to join the network at no expense. For individuals associated with a participating clinician, the cost for an NVOX assessment is set at $349, granting clinicians access to the case records and reports.
2. NVOX Direct: Through this avenue, clinicians can apply to handle NVOX Direct cases at no cost, receiving compensation for the services rendered. Individuals opting for NVOX Direct can access the service for $499, which includes the assessment, a thorough professional case review, an extensive report, and a feedback session with a professional.

The platform employs an innovative approach, aggregating various evidence types into a detailed case record that clinicians can easily navigate. It synthesizes clinical histories, functional information, and objective performance data—leveraging AI to analyze these components. This multifaceted evaluation relies on numerous factors, rather than a single questionnaire or test score, ensuring an accurate clinical assessment of the individual’s condition.

NVOX's platform is focused on ADHD assessments for individuals aged eight to fifty-seven, adapting normative reference data for age-appropriate interpretation. Additionally, an internal evidence initiative has been established to investigate the platform's methodology and findings, which will soon pave the way for external research and validation.

As part of its outreach, NVOX is actively inviting eligible mental health professionals to become part of the NVOX Network at no charge. Those interested can learn more about joining this innovative network, aiming to improve ADHD assessment while alleviating the operational burdens currently burdening clinicians. [Visit NVOX Network for more details.]

In summary, NVOX's launch of this clinical network represents a significant advancement in the field of mental health. By streamlining the ADHD assessment process, this initiative not only benefits clinicians by improving their operational efficiency but also enhances access to the necessary assessments for patients. As ADHD assessments become increasingly vital in providing proper mental health care, initiatives like the NVOX Network may redefine the landscape for both health professionals and patients alike.